The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade.
Abstract
To examine the mechanism by which free fatty acids (FFAs) induce insulin resistance in vivo, awake chronically catheterized rats underwent a hyperinsulinemic-euglycemic clamp with or without a 5-h preinfusion of lipid/heparin to raise plasma FFA concentrations. Increased plasma FFAs resulted in insulin resistance as reflected by a approximately 35% reduction in the glucose infusion rate (P < 0.05 vs. control). The insulin resistance was associated with a 40-50% reduction in 13C nuclear magnetic resonance (NMR)-determined rates of muscle glycogen synthesis (P < 0.01 vs. control) and muscle glucose oxidation (P < 0.01 vs. control), which in turn could be attributed to a approximately 25% reduction in glucose transport activity as assessed by 2-[1,2-3H]deoxyglucose uptake in vivo (P < 0.05 vs. control). This lipid-induced decrease in insulin-stimulated muscle glucose metabolism was associated with 1) a approximately 50% reduction in insulin-stimulated insulin receptor substrate (IRS)-1-associated phosphatidylinositol (PI) 3-kinase activity (P < 0.05 vs. control), 2) a blunting in insulin-stimulated IRS-1 tyrosine phosphorylation (P < 0.05, lipid-infused versus glycerol-infused), and 3) a four-fold increase in membrane-bound, or active, protein kinase C (PKC) theta (P < 0.05 vs. control). We conclude that acute elevations of plasma FFA levels for 5 h induce skeletal muscle insulin resistance in vivo via a reduction in insulin-stimulated muscle glycogen synthesis and glucose oxidation that can be attributed to reduced glucose transport activity. These changes are associated with abnormalities in the insulin signaling cascade and may be mediated by FFA activation of PKC theta.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies by our group (9, 17-20) and others (7, 21, 22) have demonstrated a strong relationship between triglyceride content in liver and muscle and insulin resistance in these tissues.”
From Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy (2002) · cites this paper as [18]
In the citing paper
“However, recent studies by our group have challenged this hypothesis and found evidence to suggest that intracellular accumulation of fatty acid-derived metabolites, such as fatty acyl CoA's, leads to activation of protein kinase Cθ , resulting in activation of a serine/threonine cascade that leads to increased serine phosphorylation of insulin receptor substrate-1 (IRS-1). IRS-1 in”
From Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy (2002) · cites this paper as [18]
In the citing paper
“In vivo, infusion of lipid emulsions and heparin in healthy subjects increased plasma NEFA concentrations to above the physiological range and were associated with the development of insulin resistance, an effect mediated by changes in post-receptor insulin signalling [149, 150, 151].”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [151]
In the citing paper
“It is well established that chronically elevated plasma FFA levels cause insulin resistance in skeletal muscle [1, 12, 14, 62–65].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [62]
In the citing paper
“Both acute (4 hours) and chronic (4 days) physiologic elevation of plasma FFA concentration in insulin sensitive individuals impairs insulin signaling and causes insulin resistance in skeletal muscle [28, 62–68].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [62]
In the citing paper
“These findings have been replicated in animal studies (rodents and rats), further expanding our understanding of the defect involving insulin signaling and action (Griffin et al., 1999; Shulman, 2014; Szendroedi et al., 2014).”
From Myosteatosis in the Context of Skeletal Muscle Function Deficit: An Interdisciplinary Workshop at the National Institute on Aging (2020) · cites this paper as Griffin et al., 1999
In the citing paper
“Similarly, infusion of lipid and heparin or heparin for 5 h caused insulin resistance in muscles that was associated with accumulation of intracellular diacylglycerol and specific activation of PKCθ.37”
From Lipid-induced insulin resistance: unravelling the mechanism (2010) · cites this paper as [37]
In the citing paper
“FFAs reduce tyrosine phosphorylation of IRS-1/2 and inhibit the PI3K/Akt pathway, leading to decreased glucose transport and decreased phosphorylation of eNOS.”
From The Vasculature in Prediabetes (2018) · cites this paper as [77]
Citations
Cites
Mechanism of free fatty acid-induced insulin resistance in humans.
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118742 · Cited by 1,539
Self-citationMeasurement of Plasma Glucose, Free Fatty Acid, Lactate, and Insulin for 24 h in Patients With NIDDM
Reaven, G. M., Hollenbeck, C., Jeng, C.-Y., Wu, M. S., & Chen, Y.-D. I. (1988) · Diabetes · doi:10.2337/diab.37.8.1020 · Cited by 753
Effects of fat on insulin-stimulated carbohydrate metabolism in normal men.
Boden, G., Jadali, F., White, J. V., Liang, Y. T., Mozzoli, M. A., Chen, X., Coleman, E., & Smith, C. R. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115399 · Cited by 494
Interaction between glucose and free fatty acid metabolism in human skeletal muscle.
Kelley, D. E., Mokáň, M., Simoneau, J. A., & Mandarino, L. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116603 · Cited by 480
Insulin resistance and lipid metabolism
Frayn, K. N. (1993) · Current Opinion in Lipidology · doi:10.1097/00041433-199306000-00004 · Cited by 254
Resistance to Insulin but Not to Glucagon in Lean Human Hypertriglyceridemics
Steiner, G. A., Morita, S., & Vranić, M. (1980) · Diabetes · doi:10.2337/diab.29.11.899 · Cited by 80
Jucker, B. M., Rennings, A. J. M., Cline, G. W., & Shulman, G. I. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10464 · Cited by 77
Self-citationElevated free fatty acid levels inhibit glucose phosphorylation in slow‐twitch rat skeletal muscle
Nolte, L. A., Galuska, D., Martin, I. K., Zierath, J. R., & Wallberg‐Henriksson, H. (1994) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1994.tb09720.x · Cited by 33
Cited by
Sorted by citations
Items 201–300 of 1,000
Molecular Targets Related to Inflammation and Insulin Resistance and Potential Interventions
Hirabara, S. M., Gorjão, R., Vinolo, M. A. R., Rodrigues, A. C., Nachbar, R. T., & Curi, R. (2012) · BioMed Research International · doi:10.1155/2012/379024 · Cited by 180
Molecular insights into insulin action and secretion
Rhodes, C. J., & White, M. F. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.32.s3.2.x · Cited by 178
Self-citationCeddia, R. B. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803025 · Cited by 184
The importance of free fatty acids in the development of Type 2 diabetes
Wilding, J. P. H. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02186.x · Cited by 178
Chang, Y., & Chuang, L. (2010) · PubMed · Cited by 174
Jové, M., Planavila, A., Sánchez, R. M., Merlos, M., Laguna, J. C., & Vázquez-Carrera, M. (2006) · Endocrinology · doi:10.1210/en.2005-0440 · Cited by 172
Insulin action in adipocytes, adipose remodeling, and systemic effects
Santoro, A. N., McGraw, T. E., & Kahn, B. B. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.03.019 · Cited by 180
Flannery, C. A., Dufour, S., Rabøl, R., Shulman, G. I., & Petersen, K. F. (2012) · Diabetes · doi:10.2337/db12-0206 · Cited by 175
Self-citationPATHOGENESIS OF TYPE 2 DIABETES
Boden, G. H. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70216-4 · Cited by 173
Kruszynska, Y. T., Worrall, D. S., Ofrecio, J. M., Frías, J. P., Macaraeg, G., & Olefsky, J. M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.1.8187 · Cited by 170
Pancreatic β-cell growth and survival – a role in obesity-linked type 2 diabetes?
Lingohr, M. K., Buettner, R., & Rhodes, C. J. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02377-8 · Cited by 168
Farese, R. V. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00045.2002 · Cited by 175
Hegarty, B. D., Cooney, G. J., Kraegen, E. W., & Furler, S. M. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1477 · Cited by 166
Self-citationAhlqvist, E., Ahluwalia, T. S., & Groop, L. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.157016 · Cited by 166
Sardu, C., Paolisso, P., Sacra, C., Mauro, C., Minicucci, F., Portoghese, M., Rizzo, M. R., Barbieri, M., Sasso, F. C., D’Onofrio, N., et al. (2019) · Diabetes Care · doi:10.2337/dc18-2356 · Cited by 168
Lipids and Glucose in Type 2 Diabetes
Boden, G. H., & Laakso, M. (2004) · Diabetes Care · doi:10.2337/diacare.27.9.2253 · Cited by 168
Mitochondrial CoQ deficiency is a common driver of mitochondrial oxidants and insulin resistance
Fazakerley, D. J., Chaudhuri, R., Yang, P., Maghzal, G. J., Thomas, K. C., Krycer, J. R., Humphrey, S. J., Parker, B. L., Fisher-Wellman, K. H., Meoli, C. C., et al. (2018) · eLife · doi:10.7554/elife.32111 · Cited by 160
Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2
Jornayvaz, F. R., Birkenfeld, A. L., Jurczak, M. J., Kanda, S., Guigni, B. A., Jiang, D. C., Zhang, D., Lee, H., Samuel, V. T., & Shulman, G. I. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103451108 · Cited by 169
Self-citationMuscular diacylglycerol metabolism and insulin resistance
Timmers, S., Schrauwen, P., & den Bosch, J. D. V. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.12.002 · Cited by 163
Basu, R., Oudit, G. Y., Wang, X., Zhang, L., Ussher, J. R., Lopaschuk, G. D., & Kassiri, Z. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00452.2009 · Cited by 161
Schmitz‐Peiffer, C., & Biden, T. J. (2008) · Diabetes · doi:10.2337/db07-1769 · Cited by 160
Cantley, J. L., Yoshimura, T., Camporez, J. P., Zhang, D., Jornayvaz, F. R., Kumashiro, N., Guebre‐Egziabher, F., Jurczak, M. J., Kahn, M., Guigni, B. A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219456110 · Cited by 162
Self-citationLocalisation and composition of skeletal muscle diacylglycerol predicts insulin resistance in humans
Bergman, B. C., Hunerdosse, D. M., Kerege, A. A., Playdon, M. C., & Perreault, L. (2012) · Diabetologia · doi:10.1007/s00125-011-2419-7 · Cited by 159
Clerk, L. H., Rattigan, S., & Clark, M. G. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1138 · Cited by 158
Effect of High-Dose Vitamin E on Insulin Resistance and Associated Parameters in Overweight Subjects
Manning, P. J., Sutherland, W. H. F., Walker, R. J., Williams, S., de Jong, S. A., Ryalls, A. R., & Berry, E. A. (2004) · Diabetes Care · doi:10.2337/diacare.27.9.2166 · Cited by 158
Perdomo, G., Commerford, S. R., Richard, A.-M. T., Adams, S. H., Corkey, B. E., O'Doherty, R. M., & Brown, N. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403566200 · Cited by 158
Taking Diabetes to Heart—Deregulation of Myocardial Lipid Metabolism in Diabetic Cardiomyopathy
Bayeva, M., Sawicki, K. T., & Ardehali, H. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000433 · Cited by 162
Houmard, J. A., Tanner, C. J., Yu, C., Cunningham, P. G., Pories, W. J., MacDonald, K. G., & Shulman, G. I. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2959 · Cited by 151
Self-citationInsulin Resistance and Mitochondrial Dysfunction
González-Franquesa, A., & Patti, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55330-6_25 · Cited by 160
Eckardt, K., Sell, H., Taube, A., Koenen, M., Platzbecker, B., Cramer, A., Horrighs, A., Lehtonen, M., Tennagels, N., & Eckel, J. (2008) · Diabetologia · doi:10.1007/s00125-008-1240-4 · Cited by 153
The Role of Mitochondria in the Pathophysiology of Skeletal Muscle Insulin Resistance
Pagel-Langenickel, I., Bao, J., Pang, L., & Sack, M. N. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0003 · Cited by 154
12/15‐Lipoxygenase Products Induce Inflammation and Impair Insulin Signaling in 3T3‐L1 Adipocytes
Chakrabarti, S. K., Cole, B. K., Wen, Y., Keller, S. R., & Nadler, J. L. (2009) · Obesity · doi:10.1038/oby.2009.192 · Cited by 153
Sarcopenic obesity: molecular clues to a better understanding of its pathogenesis?
Kob, R., Bollheimer, L. C., Bertsch, T., Fellner, C., Djukic, M., Sieber, C. C., & Fischer, B. E. (2015) · Biogerontology · doi:10.1007/s10522-014-9539-7 · Cited by 151
Mechanisms by which adiponectin reverses high fat diet-induced insulin resistance in mice
Li, X., Zhang, D., Vatner, D. F., Goedeke, L., Hirabara, S. M., Zhang, Y., Perry, R. J., & Shulman, G. I. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1922169117 · Cited by 154
Self-citationCardiometabolic characteristics of people with metabolically healthy and unhealthy obesity
Petersen, M. C., Smith, G. I., Palacios, H. H., Farabi, S. S., Yoshino, M., Yoshino, J., Cho, K., Davila-Roman, V. G., Shankaran, M., Barve, R. A., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.03.002 · Cited by 149
Self-citationKris-Etherton, P., Daniels, S., Eckel, R., Engler, M., Howard, B., Krauss, R., Lichtenstein, A., Sacks, F., Jeor, S. S. S., Stampfer, M., et al. (2001) · Circulation · doi:10.1161/01.cir.103.7.1034 · Cited by 147
Shulman, G. I. (2004) · Physiology · doi:10.1152/physiol.00007.2004 · Cited by 152
Self-citationMitochondrial dysfunction, insulin resistance, and type 2 diabetes mellitus
Abdul-Ghani, M. A., & DeFronzo, R. A. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0030-1 · Cited by 146
Age-related inflammation and insulin resistance: a review of their intricate interdependency
Park, M. H., Kim, D. H., Lee, E. K., Kim, N. D., Im, D., Lee, J., Yu, B. P., & Chung, H. Y. (2014) · Archives of Pharmacal Research · doi:10.1007/s12272-014-0474-6 · Cited by 152
Obesity and cancer, a case for insulin signaling
Poloz, Y., & Stambolic, V. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.381 · Cited by 154
Key Role for Ceramides in Mediating Insulin Resistance in Human Muscle Cells
Pickersgill, L., Litherland, G. J., Greenberg, A. S., Walker, M., & Yeaman, S. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611157200 · Cited by 150
Zhou, Q. G., Hou, F. F., Guo, Z. J., Liang, M., Wang, G. B., & Zhang, X. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.873 · Cited by 145
Choi, C. S., Kim, Y., Lee, F. N., Zabolotny, J. M., Kahn, B. B., & Youn, J. H. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00557.2001 · Cited by 145
Eitel, K., Staiger, H., Rieger, J., Mischak, H., Brandhorst, H., Brendel, M. D., Bretzel, R. G., Häring, H., & Kellerer, M. (2003) · Diabetes · doi:10.2337/diabetes.52.4.991 · Cited by 142
Briaud, I., Dickson, L. M., Lingohr, M. K., McCuaig, J., Lawrence, J., & Rhodes, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412179200 · Cited by 131
Abdul-Ghani, M. A., Muller, F. L., Liu, Y., Chavez, A. O., Balas, B., Zuo, P., Chang, Z., Tripathy, D., Jani, R., Molina-Carrion, M., et al. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90287.2008 · Cited by 140
Miele, C., Riboulet, A., Maitan, M. A., Oriente, F., Romano, C., Formisano, P., Giudicelli, J., Bèguinot, F., & OBBERGHEN, E. V. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301088200 · Cited by 141
Physical inactivity and obesity: links with insulin resistance and type 2 diabetes mellitus
Venables, M. C., & Jeukendrup, A. E. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.983 · Cited by 137
Qi, Q., Bray, G. A., Smith, S. R., Hu, F. B., Sacks, F. M., & Qi, L. (2011) · Circulation · doi:10.1161/circulationaha.111.025767 · Cited by 147
Free Fatty Acids and Skeletal Muscle Insulin Resistance
Rachek, L. I. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800101-1.00008-9 · Cited by 141
Mechanism of troglitazone action in type 2 diabetes.
Petersen, K. F., Krššák, M., Inzucchi, S. E., Cline, G. W., Dufour, S., & Shulman, G. I. (2000) · Diabetes · doi:10.2337/diabetes.49.5.827 · Cited by 136
Self-citationThe Vasculature in Prediabetes
Wasserman, D. H., Wang, T. J., & Brown, N. J. (2018) · Circulation Research · doi:10.1161/circresaha.118.311912 · Cited by 137
Getting the message across: mechanisms of physiological cross talk by adipose tissue
Lee, D.-E., Kehlenbrink, S., Lee, H., Hawkins, M. A., & Yudkin, J. S. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00015.2009 · Cited by 140
Self-citationIncreased Adiposity in Female Rhesus Monkeys Exposed to Androgen Excess During Early Gestation
Eisner, J. R., Dumesic, D. A., Kemnitz, J. W., Colman, R. J., & Abbott, D. H. (2003) · Obesity Research · doi:10.1038/oby.2003.42 · Cited by 133
Muscle Long‐Chain Acyl CoA Esters and Insulin Resistance
Cooney, G. J., Thompson, A. L., Furler, S. M., Ye, J.-M., & Kraegen, E. W. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04276.x · Cited by 131
Self-citationNagle, C. A., An, J., Shiota, M., Torres, T. P., Cline, G. W., Liu, Z., Wang, S., Catlin, R. L., Shulman, G. I., Newgard, C. B., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611550200 · Cited by 136
Self-citationPark, J.-J., Berggren, J. R., Hulver, M. W., Houmard, J. A., & Hoffman, E. P. (2006) · Physiological Genomics · doi:10.1152/physiolgenomics.00045.2006 · Cited by 135
Qiu, S., Vazquez, J. T., Boulger, E., Liu, H., Xue, P., Hussain, M. A., & Wolfe, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-01937-4 · Cited by 135
The metabolic abnormalities associated with non-alcoholic fatty liver disease
Haque, M., & Sanyal, A. J. (2002) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2002.0325 · Cited by 136
Altered Skeletal Muscle Lipase Expression and Activity Contribute to Insulin Resistance in Humans
Badin, P.-M., Louche, K., Mairal, A., Liebisch, G., Schmitz, G., Rustan, A. C., Smith, S. R., Langin, D., & Moro, C. (2011) · Diabetes · doi:10.2337/db10-1364 · Cited by 132
Jové, M., Planavila, A., Laguna, J. C., & Vázquez-Carrera, M. (2005) · Endocrinology · doi:10.1210/en.2004-1560 · Cited by 133
Metabolic Stress Signaling Mediated by Mixed-Lineage Kinases
Jaeschke, A., & Davis, R. J. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.07.008 · Cited by 137
Dynamic MRS and MRI of skeletal muscle function and biomechanics
Prompers, J. J., Jeneson, J. A. L., Drost, M. R., Oomens, C., Strijkers, G. J., & Nicolay, K. (2006) · NMR in Biomedicine · doi:10.1002/nbm.1095 · Cited by 135
Metabolomics in diabetes research
Friedrich, N. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0120 · Cited by 138
Rueda‐Clausen, C. F., Dolinsky, V. W., Morton, J. S., Proctor, S. D., Dyck, J. R. B., & Davidge, S. T. (2011) · Diabetes · doi:10.2337/db10-1239 · Cited by 132
The peripheral GABAergic system as a target in endocrine disorders
Gladkevich, A. V., Korf, J., Hakobyan, V. P., & Melkonian, K. V. (2005) · Autonomic Neuroscience · doi:10.1016/j.autneu.2005.11.002 · Cited by 132
Chen, H. C., Stone, S. J., Zhou, P., Buhman, K. K., & Farese, R. V. (2002) · Diabetes · doi:10.2337/diabetes.51.11.3189 · Cited by 134
Impaired mitochondrial fat oxidation induces adaptive remodeling of muscle metabolism
Wicks, S. E., Vandanmagsar, B., Haynie, K. R., Fuller, S. E., Warfel, J. D., Stephens, J. M., Wang, M., Han, X., Zhang, J., Noland, R. C., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1418560112 · Cited by 131
Perilipin Expression in Human Adipose Tissue Is Elevated with Obesity
Kern, P. A., Gregorio, G. B. D., Lu, T., Rassouli, N., & Ranganathan, G. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031388 · Cited by 132
Muoio, D. M., & Koves, T. R. (2007) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h07-083 · Cited by 129
Ahn, J., Lee, H., Jung, C. H., & Ha, T. Y. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200182 · Cited by 129
Molecular mechanisms of lipid‐induced insulin resistance in muscle, liver and vasculature
Krebs, M., & Roden, M. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00439.x · Cited by 130
Insulin action and signalling in fat and muscle from dexamethasone-treated rats
Burén, J., Lai, Y. C., Lundgren, M., Eriksson, J. W., & Jensen, J. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.02.034 · Cited by 125
Jornayvaz, F. R., Samuel, V. T., & Shulman, G. I. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104726 · Cited by 132
Self-citationMorino, K., Neschen, S., Bilz, S., Sono, S., Tsirigotis, D., Reznick, R. M., Moore, I., Nagai, Y., Samuel, V., Sebastian, D., et al. (2008) · Diabetes · doi:10.2337/db06-0454 · Cited by 125
Self-citationKanamoto, Y., Yamashita, Y., Nanba, F., Yoshida, T., Tsuda, T., Fukuda, I., Nakamura‐Tsuruta, S., & Ashida, H. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf201471p · Cited by 127
Mulder, H., Sörhede‐Winzell, M., Contreras, J. A., Fex, M., Ström, K., Ploug, T., Galbo, H., Arner, P., Lundberg, C., Sundler, F., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213032200 · Cited by 125
Kraegen, E. W., Saha, A. K., Preston, E., Wilks, D. L., Hoy, A. J., Cooney, G. J., & Ruderman, N. B. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00316.2005 · Cited by 126
Self-citationSchenk, S., Harber, M. P., Shrivastava, C. R., Burant, C., & Horowitz, J. F. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.175489 · Cited by 125
Radin, M. S., Sinha, S., Bhatt, B. A., Dedousis, N. L., & O'Doherty, R. M. (2007) · Diabetologia · doi:10.1007/s00125-007-0861-3 · Cited by 125
Intercellular signaling between adipose tissue and muscle tissue
Kokta, T. A., Dodson, M. V., Gertler, A., & Hill, R. A. (2004) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2004.05.004 · Cited by 124
Protein Kinase C and Lipid‐Induced Insulin Resistance in Skeletal Muscle
Schmitz‐Peiffer, C. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04272.x · Cited by 124
Augustus, A. S., Yagyu, H., Haemmerle, G., Bensadoun, A., Vikramadithyan, R. K., Park, S., Kim, J. K., Zechner, R., & Goldberg, I. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401028200 · Cited by 122
Assini, J. M., Mulvihill, E. E., Burke, A. C., Sutherland, B. G., Telford, D. E., Chhoker, S. S., Sawyez, C. G., Drangova, M., Adams, A. C., Kharitonenkov, A., et al. (2015) · Endocrinology · doi:10.1210/en.2014-2003 · Cited by 119
García‐Ruiz, C., Baulies, A., Marí, M., García-Rovés, P. M., & Fernández-Checa, J. C. (2013) · Free Radical Research · doi:10.3109/10715762.2013.830717 · Cited by 119
Metabolomics – the complementary field in systems biology: a review on obesity and type 2 diabetes
Bakar, M. H. A., Sarmidi, M. R., Cheng, K., Khan, A. A., Suan, C. L., Huri, H. Z., & Yaakob, H. (2015) · Molecular BioSystems · doi:10.1039/c5mb00158g · Cited by 120
Ragheb, R., Shanab, G. M. L., Medhat, A. M., Seoudi, D. M., Adeli, K., & Fantus, I. G. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.08.106 · Cited by 119
Tai, C. C., & Ding, S. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.09.010 · Cited by 123
Inflamed adipose tissue, insulin resistance and vascular injury
Andersson, C. X., Gustafson, B., Hammarstedt, A., Hedjazifar, S., & Smith, U. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.889 · Cited by 118
Guo, L., & Tabrizchi, R. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.10.009 · Cited by 117
Variants in the Calpain-10 Gene Predispose to Insulin Resistance and Elevated Free Fatty Acid Levels
Orho‐Melander, M., Klannemark, M., Svensson, M., Ridderstråle, M., Lindgren, C. M., & Groop, L. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2658 · Cited by 117
Molecular mechanism of insulin resistance
Bhattacharya, S., Dey, D., & Roy, S. S. (2007) · Journal of Biosciences · doi:10.1007/s12038-007-0038-8 · Cited by 119
Atherogenic dyslipidemia associated with metabolic syndrome and insulin resistance
Grundy, S. M. (2006) · Clinical cornerstone · doi:10.1016/s1098-3597(06)80005-0 · Cited by 116
The effect of PPARγ ligands on the adipose tissue in insulin resistance
Hammarstedt, A., Andersson, C. X., Sopasakis, V. R., & Smith, U. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.04.008 · Cited by 119
Zammit, V. A. (2013) · Biochemical Journal · doi:10.1042/bj20121689 · Cited by 115
Mencarelli, A., Cipriani, S., Renga, B., Bruno, A. M., D’Amore, C., Distrutti, E., & Fiorucci, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045425 · Cited by 119
Caballero, A. E. (2004) · Current Diabetes Reports · doi:10.1007/s11892-004-0074-9 · Cited by 114
Ryan, K. K., Woods, S. C., & Seeley, R. J. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.013 · Cited by 114
Non-alcoholic fatty liver disease and insulin resistance: From bench to bedside
Gariani, K., Philippé, J., & Jornayvaz, F. R. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.11.002 · Cited by 113
Guo, X., Zhang, D., Gao, X., Parry, J. W., Liu, K., Liu, B., & Wang, M. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200569 · Cited by 113
Metadata
- Authors
- Griffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F., & Shulman, G. I.
- Affiliations
- Yale University (US)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1999-06-01
- Volume
- 48
- Issue
- 6
- Pages
- 1270-1274
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2043106623
- Cited by
- 1,267
- References
- 8
- Citations by year
- 2026: 15 · 2025: 18 · 2024: 21 · 2023: 18 · 2022: 29 · 2021: 23 · 2020: 26 · 2019: 32 · 2018: 38 · 2017: 32 · 2016: 35 · 2015: 69 · 2014: 51 · 2013: 56 · 2012: 64
- FWCI
- 13.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK45735, R01-DK40936, R01DK040936, P30DK045735)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- free fatty acids, insulin resistance, protein kinase C theta, insulin signaling, skeletal muscle, muscle glycogen synthesis, glucose transport, IRS-1, PI3-kinase, IRS-1 tyrosine phosphorylation, hyperinsulinemic-euglycemic clamp, lipid infusion
- MeSH terms
- Protein Kinase C-theta, Animals, Deoxyglucose, Enzyme Activation, Fatty Acids, Nonesterified, Insulin, Insulin Resistance, Isoenzymes, Male, Magnetic Resonance Spectroscopy, Phosphoproteins, Phosphorylation, Protein Kinase C, Tyrosine, Signal Transduction, Zinc Fingers, Rats, Sprague-Dawley, Muscle, Skeletal, Phosphatidylinositol 3-Kinases, Rats, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
